Literature DB >> 18074684

Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue.

Thomas H Milhorat1, Paolo A Bolognese, Misao Nishikawa, Nazli B McDonnell, Clair A Francomano.   

Abstract

OBJECT: Chiari malformation Type I (CM-I) is generally regarded as a disorder of the paraxial mesoderm. The authors report an association between CM-I and hereditary disorders of connective tissue (HDCT) that can present with lower brainstem symptoms attributable to occipitoatlantoaxial hypermobility and cranial settling.
METHODS: The prevalence of HDCT was determined in a prospectively accrued cohort of 2813 patients with CM-I. All patients underwent a detailed medical and neuroradiological workup that included an assessment of articular mobility. Osseous structures composing the craniocervical junction were investigated morphometrically using reconstructed 3D computed tomography and plain x-ray images in 114 patients with HDCT/CM-I, and the results were compared with those obtained in patients with CM-I (55 cases) and healthy control individuals (55 cases).
RESULTS: The diagnostic criteria for Ehlers-Danlos syndrome and related HDCT were met in 357 (12.7%) of the 2813 cases. Hereditability was generally compatible with a pattern of autosomal dominant transmission with variable expressivity. The diagnostic features of HDCT/CM-I were distinguished from those of CM-I by clinical stigmata of connective tissue disease, a greater female preponderance (8:1 compared with 3:1, p < 0.001), and a greater incidence of lower brainstem symptoms (0.41 compared with 0.11, p < 0.001), retroodontoid pannus formation (0.71 compared with 0.11, p < 0.001), and hypoplasia of the oropharynx (0.44 compared with 0.02, p < 0.001). Measurements of the basion-dens interval, basion-atlas interval, atlas-dens interval, dens-atlas interval, clivus-atlas angle, clivus-axis angle, and atlas-axis angle were the same in the supine and upright positions in healthy control individuals and patients with CM-I. In patients with HDCT/CM-I, there was a reduction of the basion-dens interval (3.6 mm, p < 0.001), an enlargement of the basion-atlas interval (3.0 mm, p < 0.001), and a reduction of the clivus-axis angle (10.8 degrees, p < 0.001), clivus-atlas angle (5.8 degrees, p < 0.001), and atlas-axis angle (5.3 degrees, p < 0.001) on assumption of the upright position. These changes were reducible by cervical traction or returning to the supine position.
CONCLUSIONS: The identification of HDCT in 357 patients with CM-I establishes an association between two presumably unrelated mesodermal disorders. Morphometric evidence in this cohort-cranial settling, posterior gliding of the occipital condyles, and reduction of the clivus-axis angle, clivus-atlas angle, and atlas-axis angle in the upright position-suggests that hypermobility of the occipitoatlantal and atlantoaxial joints contributes to retroodontoid pannus formation and symptoms referable to basilar impression.

Entities:  

Mesh:

Year:  2007        PMID: 18074684     DOI: 10.3171/SPI-07/12/601

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  55 in total

1.  Tapering of the cervical spinal canal in patients with Chiari I malformations.

Authors:  M Hirano; V Haughton; A Munoz del Rio
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

Review 2.  High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities.

Authors:  Karen W Gripp; Elizabeth Hopkins; Daniel Doyle; William B Dobyns
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

3.  Chiari I Malformation and Basilar Invagination in Fibrous Dysplasia: Prevalence, Mechanisms, and Clinical Implications.

Authors:  Kristen S Pan; John D Heiss; Sydney M Brown; Michael T Collins; Alison M Boyce
Journal:  J Bone Miner Res       Date:  2018-08-03       Impact factor: 6.741

4.  Chiari I-a 'not so' congenital malformation?

Authors:  Dominic N P Thompson
Journal:  Childs Nerv Syst       Date:  2019-07-10       Impact factor: 1.475

5.  Management of Chiari I malformations: a paradigm in evolution.

Authors:  H Alexander; D Tsering; J S Myseros; S N Magge; C Oluigbo; C E Sanchez; Robert F Keating
Journal:  Childs Nerv Syst       Date:  2019-07-27       Impact factor: 1.475

6.  Clinical, radiological, and genetic similarities between patients with Chiari Type I and Type 0 malformations.

Authors:  Christina A Markunas; R Shane Tubbs; Roham Moftakhar; Allison E Ashley-Koch; Simon G Gregory; W Jerry Oakes; Marcy C Speer; Bermans J Iskandar
Journal:  J Neurosurg Pediatr       Date:  2012-04       Impact factor: 2.375

7.  Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management.

Authors:  Thomas H Milhorat; Misao Nishikawa; Roger W Kula; Yosef D Dlugacz
Journal:  Acta Neurochir (Wien)       Date:  2010-05-04       Impact factor: 2.216

Review 8.  Positional Magnetic Resonance Imaging for People With Ehlers-Danlos Syndrome or Suspected Craniovertebral or Cervical Spine Abnormalities: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2015-07-01

9.  Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features.

Authors:  Santhi K Ganesh; Rachel Morissette; Zhi Xu; Florian Schoenhoff; Benjamin F Griswold; Jiandong Yang; Lan Tong; Min-Lee Yang; Kristina Hunker; Leslie Sloper; Shinie Kuo; Rafi Raza; Dianna M Milewicz; Clair A Francomano; Harry C Dietz; Jennifer Van Eyk; Nazli B McDonnell
Journal:  FASEB J       Date:  2014-04-14       Impact factor: 5.191

10.  Prevalence and Impact of Underlying Diagnosis and Comorbidities on Chiari 1 Malformation.

Authors:  Brooke Sadler; Timothy Kuensting; Jennifer Strahle; Tae Sung Park; Matthew Smyth; David D Limbrick; Matthew B Dobbs; Gabe Haller; Christina A Gurnett
Journal:  Pediatr Neurol       Date:  2020-01-21       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.